Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

from

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.

Subscribe to the Merantix Momentum Newsletter now.

The latest industry news, interviews, technologies and resources.

Why compliance officers can no longer afford to ignore AI

Compliance teams in Switzerland are faced with a flood of regulations. Find out how AI is easing the burden on banks, insurance companies and law firms - and making compliance smarter.

From bottleneck to breakthrough: Why AI is crucial for progress in healthcare and pharma

Rising costs, a shortage of specialists and a flood of data are pushing the healthcare system and the pharmaceutical industry to their limits. Why artificial intelligence is now the key to taking care, research and development to a new level.

Article

DNA-Encoded Libraries and AI for Compound Identification

An expert interview on the use of DNA-encoded libraries for connection detection.

Article

Reliable and crisis-resistant inventory optimization

Revolutionizing supply chain optimization.

Article

AI-Driven Compound Optimization in the Large Molecule Space

An expert interview on AI-Driven Compound Optimization in the Large Molecule Space.

Data-driven to the drug of tomorrow

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.